Global Oral Cancer Diagnostics Market Size by Indication (Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma), by Diagnosis Type (Endoscopy, Biopsy, X-Ray, CT, PET), & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261435
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Oral cancer is a broad category that includes a number of conditions such as cancers of lips, tongue, cheeks, hard and soft palate, the floor of the mouth, pharynx, and sinuses. Early diagnosis of oral cancer is extremely crucial as the treatment of the disease is dependent on the stage of cancer, and earlier the diagnosis, the easier it is to treat the cancerous growth.

The global oral cancer diagnostics market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The increase in population suffering from oral cancer, rise in the adoption rate of effective diagnostic aids for the detection of oral cancer coupled with the advances in research, and rise in risk factors that lead to cancer are expected to enhance the market growth globally. However, the shortage of trained professionals and the unaffordability of healthcare organizations to purchase new imaging systems are the major factors expected to hamper the growth of the global market.

The global oral cancer diagnostics market is primarily segmented based on different indication, diagnosis type, and regions. On the basis of indication, the market is divided into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma (salivary gland), oral cavity lymphomas, and others. Depending on diagnosis type, it is categorized into endoscopy, biopsy, X-ray, computed tomography (CT), positron emission tomography (PET), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of indication, the market is split into:
* Oral Squamous Cell Carcinoma
* Mucoepidermoid Carcinoma (Salivary Gland)
* Oral Verrucous Carcinoma
* Oral Cavity Lymphomas
* Other Indications

On the basis of diagnosis type, the market is split into:
* Computed Tomography (CT) Scan
* Positron Emission Tomography (PET)
* Biopsy
* X-Ray
* Endoscopy
* Other Types

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* GE Healthcare
* F. Hoffmann-La Roche Ltd.
* Siemens Healthineers
* Hitachi Ltd
* PeriRx, LLC
* Canon Medical Systems Corporation
* Vigilant Biosciences, Inc.
* QIAGEN
* Koninklijke Philips NV
* Randox Laboratories Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, indication, and diagnosis type market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, indication, and diagnosis type with qualitative and quantitative information and facts

Target Audience:
* Oral Cancer Diagnostics Equipment Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Oral Cancer Diagnostics Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Oral Cancer Diagnostics Market - Porter\'s Five Forces Analysis
4.4. Global Oral Cancer Diagnostics Market - PESTEL Analysis

5. Global Oral Cancer Diagnostics Market, by Indication
5.1. Global Oral Cancer Diagnostics Market, Size and Forecast, 2015-2026
5.2. Global Oral Cancer Diagnostics Market, by Oral Squamous Cell Carcinoma, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Oral Cancer Diagnostics Market, by Mucoepidermoid Carcinoma, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Oral Cancer Diagnostics Market, by Oral Verrucous Carcinoma, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Oral Cancer Diagnostics Market, by Oral Cavity Lymphomas, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Oral Cancer Diagnostics Market, by Other Indications, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Oral Cancer Diagnostics Market, by Diagnosis Type
6.1. Global Oral Cancer Diagnostics Market, Size and Forecast, 2015-2026
6.2. Global Oral Cancer Diagnostics Market, for Computed Tomography (CT) Scan, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Oral Cancer Diagnostics Market, for Positron Emission Tomography, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Oral Cancer Diagnostics Market, for Biopsy, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Oral Cancer Diagnostics Market, for X-Ray, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026
6.6. Global Oral Cancer Diagnostics Market, for Endoscopy, 2015-2026
6.6.1. Key driving factors, trends and opportunities
6.6.2. Market size and forecast, 2015-2026
6.7. Global Oral Cancer Diagnostics Market, for Other Types, 2015-2026
6.7.1. Key driving factors, trends and opportunities
6.7.2. Market size and forecast, 2015-2026

7. Global Oral Cancer Diagnostics Market, by Region
7.1. Oral Cancer Diagnostics Market Regional Analysis, 2015-2026
7.2. Global Oral Cancer Diagnostics Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Oral Cancer Diagnostics Market, 2015-2026
7.3.1. North America Oral Cancer Diagnostics Market Size and Forecast, 2015-2026
7.3.2. North America Oral Cancer Diagnostics Market by Country, 2015-2026
7.3.2.1. U.S. Oral Cancer Diagnostics Market, 2015-2026
7.3.2.2. Canada Oral Cancer Diagnostics Market, 2015-2026
7.4. Europe Oral Cancer Diagnostics Market, 2015-2026
7.4.1. Europe Oral Cancer Diagnostics Market Size and Forecast, 2015-2026
7.4.2. Europe Oral Cancer Diagnostics Market by Country, 2015-2026
7.4.2.1. Germany Oral Cancer Diagnostics Market, 2015-2026
7.4.2.2. France Oral Cancer Diagnostics Market, 2015-2026
7.4.2.3. Italy Oral Cancer Diagnostics Market, 2015-2026
7.4.2.4. UK Oral Cancer Diagnostics Market, 2015-2026
7.4.2.5. Spain Oral Cancer Diagnostics Market, 2015-2026
7.4.2.6. Rest of Europe Oral Cancer Diagnostics Market, 2015-2026
7.5. Asia Pacific Oral Cancer Diagnostics Market, 2015-2026
7.5.1. Asia Pacific Oral Cancer Diagnostics Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Oral Cancer Diagnostics Market by Country, 2015-2026
7.5.2.1. Japan Oral Cancer Diagnostics Market, 2015-2026
7.5.2.2. China Oral Cancer Diagnostics Market, 2015-2026
7.5.2.3. India Oral Cancer Diagnostics Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Oral Cancer Diagnostics Market, 2015-2026
7.6. South America Oral Cancer Diagnostics Market, 2015-2026
7.6.1. South America Oral Cancer Diagnostics Market Size and Forecast, 2015-2026
7.6.2. South America Oral Cancer Diagnostics Market by Country, 2015-2026
7.6.2.1. Mexico Oral Cancer Diagnostics Market, 2015-2026
7.6.2.2. Brazil Oral Cancer Diagnostics Market, 2015-2026
7.6.2.3. Rest of South America Oral Cancer Diagnostics Market, 2015-2026
7.7. Middle East & Africa Oral Cancer Diagnostics Market, 2015-2026
7.7.1. Middle East & Africa Oral Cancer Diagnostics Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Oral Cancer Diagnostics Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Oral Cancer Diagnostics Market, 2015-2026
7.7.2.2. South Africa Oral Cancer Diagnostics Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Oral Cancer Diagnostics Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. GE Healthcare
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. F. Hoffmann-La Roche Ltd.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Siemens Healthineers
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Hitachi Ltd.
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. QIAGEN N.V.
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. PeriRx, LLC
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Canon Medical Systems Corporation
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Vigilant Biosciences, Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Koninklijke Philips NV
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Randox Laboratories Ltd.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type